Iterum Therapeutics
(ITRM) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
2.03
2.78%
Pre-market Jan 07, 2025, 04:18 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -38.37M | -44.43M | -91.56M | -52.01M | -103.13M | -77.06M | -29.41M | -13.46M |
Depreciation & Amortization | 1.75M | 1.80M | 2.10M | 161.00K | 152.00K | 136.00K | 65.00K | n/a |
Stock-Based Compensation | 784.00K | 4.76M | 4.32M | 2.76M | 2.17M | 1.29M | 392.00K | 348.00K |
Other Working Capital | 540.00K | 416.00K | -503.00K | -9.88M | 6.45M | -2.45M | -3.27M | 630.00K |
Other Non-Cash Items | -6.26M | 17.09M | 8.14M | 17.71M | 4.15M | 2.04M | -95.00K | -830.00K |
Deferred Income Tax | n/a | n/a | 61.60M | 1.41M | -125.00K | -701.00K | 44.00K | n/a |
Change in Working Capital | 2.76M | 2.31M | -440.00K | -24.56M | 17.90M | -1.60M | -1.60M | 1.82M |
Operating Cash Flow | -39.33M | -18.47M | -15.84M | -54.53M | -78.89M | -75.89M | -30.60M | -11.30M |
Capital Expenditures | -13.00K | -62.00K | -61.00K | -11.00K | -24.00K | -90.00K | -812.00K | n/a |
Acquisitions | n/a | -14.02K | 54.53K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -41.18M | -45.71M | -67.03M | n/a | n/a | -96.49M | -53.27M | n/a |
Sales Maturities Of Investments | 64.53M | 59.73M | 12.50M | n/a | 40.13M | 87.92M | 22.50M | n/a |
Other Investing Acitivies | n/a | 14.02K | -54.53K | n/a | 40.13K | -8.57K | -30.77K | n/a |
Investing Cash Flow | 23.34M | 13.96M | -54.59M | -11.00K | 40.10M | -8.66M | -31.59M | n/a |
Debt Repayment | n/a | -2.25M | -6.52M | -5.49M | -1.03M | 14.51M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 433.00K | n/a | n/a | 60.00K | 32.17M | 45.87M | 20.85M |
Financial Cash Flow | 1.03M | -1.82M | 83.13M | 64.47M | -974.00K | 120.84M | 45.87M | 20.85M |
Net Cash Flow | -15.02M | -6.38M | 12.69M | 9.93M | -39.78M | 36.19M | -16.32M | 9.55M |
Free Cash Flow | -39.34M | -18.54M | -15.90M | -54.54M | -78.91M | -75.98M | -31.42M | -11.30M |